Protein Kinase A inhibitor fragment 14-22, myristoylated trifluoroacetate salt
SIGMA/P9115 - ≥90% (HPLC), lyophilized powder
Empirical Formula (Hill Notation): C53H98N20O12 · C2HF3O2
Molecular Weight: 1321.50
MDL Number: MFCD03788010
Linear Formula: C53H98N20O12 · C2HF3O2
Product Type: Chemical
| assay | ≥90% (HPLC) |
| form | lyophilized powder |
| InChI | 1S/C53H100N20O12.C2HF3O2/ |
| InChI key | DBHNUJXUTKVLID-UXBYPZMDSA |
| Quality Level | 100 ![]() |
| SMILES string | OC(=O)C(F)(F)F.CCCCCCCCCC |
| solubility | H2O: soluble |
| storage temp. | −20°C |
| Amino Acid Sequence: | Myr-Gly-Arg-Thr-Gly-Arg-A |
| Application: | Protein kinase A inhibitor fragment 14-22, myristoylated trifluoroacetate salt has been used in cell culture for pharmaceutical inhibition and activation studies. |
| Biochem/physiol Actions: | Cell permeable cAMP-dependent protein kinase (PKA) inhibitor |
| Biochem/physiol Actions: | Mutations in the gene encoding protein kinase cAMP-activated catalytic subunit-α (PRKACA) have been associated with Cushing’s syndrome. |
| General description: | Protein kinase A inhibitor fragment 14-22, myristoylated trifluoroacetate salt inhibits the protein kinase cAMP-activated catalytic subunit-α (PRKACA). The gene encoding it is localized on human chromosome 19p13.1. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥90% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352204 |

